Phase 1b Study of MEHD7945A (DULIGOTUZUMAB) Plus Cisplatin/Fluorouracil or Carboplatin/Paclitaxel for First-Line Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck

P.M. Clement,1 J-P. Machiels,2 L. Wirth,3 P. Specenier,4 T. Seiwert,5 F. Mardjuadi,2 X. Wang,7 A. Kapp,7 S. Royer-Joo,7 E. Penuel,7 B. McCall,7 A. Pirzkall,7 A. Jimeno6 1KU Leuven, Leuven, Belgium; 2Cliniques Universitaires Saint-Luc, Universite Catholique de Louvain, Brussels, Belgium; 3Massachusetts General Hospital, Boston, USA; 4Universitair Ziekenhuis Antwerpen, Edegem, Belgium; 5University of Chicago, Chicago, USA; 6University Colorado, Aurora, USA; 7Genentech, Inc., South San Francisco, CA, USA